Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
110
RETICULOCYTE COUNT, BLOOD
Method:
Flux cytometry.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Both 0 2 Weeks 25.00 - 65.00 por mil * 0.1 = %
Females 2.00 - 25.00 por mil * 0.1 = %
Males 5.00 - 28.00 por mil * 0.1 = %
225
REPTILASE TIME, PLASMA
Method:
Coagulometry.
Mounting:
Delivery period:4
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
Centrifuge.
Separate plasma.
Freeze specimen immediately.
Reference V.:
Tiempo Paciente:
16.00 - 22.00 seg.
253
RISTOCETIN COFACTOR (VON WILLEBRAND), PLASMA
Method:
Turbidimetry.
Mounting:
Delivery period:5
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Reference V.:
50.00 - 150.00 %
Review:
05/03/2004
262
Rh FACTOR (Anti - D), BLOOD
Mounting:
Delivery period:2
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
05/07/2010
264
Rh FACTOR (Anti - Du), BLOOD
Method:
Gel column.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
14/04/2010
682
RETINOL BINDING PROTEIN, SERUM
Method:
Immunonephelometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
30.00 - 60.00 mg/L * 0.1 = mg/dL
Review:
09/12/2010
760
REACTIVE C PROTEIN (ULTRASENSITIVE), SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Intermediate relative risk1.00 - 3.00 mg/L * 10.0 = mg/dL
High relative risk:
> 3.00 mg/L * 10.0 = mg/dL
Low relative risk:
< 1.00 mg/L * 10.0 = mg/dL
764
REACTIVE C PROTEIN, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
< 5.00 mg/L * 0.1 = mg/dL
Review:
09/04/2013
765
RHEUMATOID FACTOR, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 14.00 KUI/L * 1 = UI/mL
Review:
09/04/2013
1100
REVERSE T-3 (RT3), SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Plasma (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
0.10 - 0.35 ug/L * 1 = ng/mL
Review:
11/03/2009
1108
RATIO T4/TBG, SERUM
Method:
Calculation
Mounting:
Delivery period:5
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Índice T4/TBG:
Males 4.00 - 8.00 Índice
Females 3.90 - 6.30 Índice
Review:
01/09/2010
1151
RATIO HCG FRACTION BETA, CSF AND SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 3.00 UI/L
< 2.00
< 5.00 UI/L
Review:
25/09/2015
1309
RISPERIDONE + 9-HIDROXIRISPERIDONE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
RISPERIDONA:
1.00 - 10.00 ug/L
Risperidona+9-OHRisperidona:
10.00 - 110.00 ug/L
Review:
18/01/2011
1361
RATIO ALDOSTERONE/RENINE
Method:
Calculation
Mounting:
Delivery period:4
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
0.00 - 0.69 nmol/L-ng/mL/h * 36.1011 = ng/dL-ng/mL/h
Standing position 0.60 - 4.18 ng/mL/h
Supine position 0.32 - 1.84 ng/mL/h
ALDOSTERONA:

Standing position 0.09 - 0.83 nmol/L * 361.011 = ng/L
Supine position 0.02 - 0.42 nmol/L * 361.011 = ng/L
Review:
01/12/2015
1372
RUBELLA VIRUS ANTIBODIES, IgG (AVIDITY), SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 40.00 - 60.00 %
High avidity:
> 60.00 %
Low avidity:
< 40.00 %
R.Values:
A low Rubella IgG avidity result indicates primary acute infection.
A high Rubella IgG avidity result excludes primary infection in last 6 weeks.
An intermediate Rubella IgG avidity indicates primary infection in last 6 weeks.
1515
RICKETTSIA CONORII ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/48 Titulo
Negative:
< 1/48 Titulo
Review:
21/01/2009
1516
RICKETTSIA MOOSERI ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
1528
RETICULIN ANTIBODIES, IgA, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
1531
RESPIRATORY SYNCITIAL VIRUS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/40 Titulo
Positive:
>= to 1/40 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
21/01/2009
1532
RESPIRATORY SYNCITIAL VIRUS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/20 Titulo
Positive:
>= to 1/20 Titulo
Review:
21/01/2009
1557
RUBELLA VIRUS ANTIBODIES, IgM, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 0.99 Indice
Negative:
< 0.80 Indice
Indeterminate:
0.80 - 0.99 Indice
Review:
09/04/2013
1558
RUBELLA VIRUS ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 5.00 - 9.99 UI/mL
Positive:
> 9.99 UI/mL
Negative:
< 5.00 UI/mL
Review:
09/04/2013
1559
RETICULIN ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
1634
RICKETTSIA CONORII ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/80 Titulo
Positive:
>= to 1/80 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
28/04/2009
1635
RICKETTSIA MOOSERI ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
1637
RICKETTSIA CONORII ANTIBODIES, IgG, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/2 Titulo
Negative:
< 1/2 Titulo
1700
RUBELLA VIRUS RNA, AMNIOTIC FLUID
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
1 mL Amniotic fluid (-8 ºC - Freeze)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Negative
Review:
22/03/2004
1729
Ri ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
23/06/2013
2487
REARRANGEMENT BCL2/IgH t(14;18)(q32;q21), BONE MARROW
Method:
Real Time PCR.
Mounting:
Delivery period:10
Sample:
Alt. 2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
2572
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 240 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 4 h Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
2573
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 360 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 6 h. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin sodium as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
2768
REARRANGEMENT BCL6 GENE (3q27.3 REGION: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Sample:
3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
15/03/2014
2955
RETINOBLASTOMA (RB1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:61
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
07/06/2004
5032
RESPIRATORY CYTOLOGY
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:5
Sample:
Alt. 1 mL BAS (2-8 ºC - Refrigerate)
Alt. 1 mL Sputum/phlegm (2-8 ºC - Refrigerate)
R.Values:
Reported for each case.
Review:
30/05/2008
6079
RESIDUAL CHLORINE FREE, DRINKING WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
50 mL Water (Recipient, plastic)
Transport:
Protect from light.
RD 140/2003:
< 1.00 mg/L
Review:
09/05/2008
6705
RESIDUAL CHLORINE FREE, WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
50 mL Water (Recipient, plastic)
Transport:
Protect from light.
Parametric V.:
Not established.
6832
RESIDUAL CHLORINE FREE, DIALYSATE WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
50 mL Dialysis water (Recipient, plastic)
Transport:
Protect from light.
Parametric V.:
Not established.
7030
REACTIVE STRIP, URINE
Method:
Reflexion Spectrometry.
Mounting:
Delivery period:1
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
Aspecto:
Reported for each case
Bilirrubina:
Negative
Color:
Reported for each case
Cuerpos cetónicos:
Negative
Densidad:
Reported for each case
Leucocitos:
Negative
Nitritos:
Negative
pH:
5.00 - 7.50
Proteinas:
< 15.00 mg/dL
Sangre:
0.00 - 5.00 eri/uL
Urobilinogeno:
Negative
Review:
02/02/2010
7041
RESPIRATORY SYNCITIAL VIRUS ANTIGEN, RESPIRATORY SAMPLE
Method:
EIA Chromatography.
Mounting:
Delivery period:2
Sample:
1 mL Nasopharyngeal aspiration Physiological serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
7046
ROTAVIRUS ANTIGEN, FECAL
Method:
Latex particle agglutination.
Mounting:
Delivery period:1
Sample:
2 g Faeces (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
Negative
Review:
01/04/2005
7055
REDUCING SUBSTANCE, URINE
Method:
Colorimetry.
Mounting:
Delivery period:2
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
< 0.50 g/dL.
Review:
07/05/2010
7056
REDUCING BODIES, FECAL
Method:
Colorimetry.
Mounting:
Delivery period:2
Sample:
2 g Faeces (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
< 0.50 g/dL
Review:
12/05/2010
7408
RECTAL SMEAR, BLEE/CARB SCREENING
Method:
Bacteriologic culture in specific media.
Mounting:
Delivery period:2
Sample:
1 Sample/s Smear (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8025
REARRANGEMENT MLL GENE (11q23.3 REGION: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Sample:
3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
15/03/2014
8055
RECOVERIN ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:16
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
28/10/2009
8170
RETT SYNDROME (MECP2 GENE: SEQUENCING), BLOOD
Method:
Sequencing.
Mounting:
Delivery period:40
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/05/2013
8276
RNA TYROSINASE (CIRCULATING CELLS), BLOOD
Method:
RT-PCR.
Mounting:
Delivery period:21
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Negative
8301
RhD ZYGOSITY STUDY, BLOOD
Method:
QF-PCR.
Mounting:
Delivery period:13
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
Reported for each case
Review:
24/04/2007
8473
RABIES VIRUS ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.50 KUI/L
Review:
08/10/2009
8588
RUBINSTEIN TAYBI SYNDROME (Del 16p13.3: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:25
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
24/11/2008
8644
RECEPTOR INSULINE ANTIBODIES, SERUM
Method:
Radioimmunoprecipitation.
Mounting:
Delivery period:10
Sample:
1 mL Serum (-8 ºC - Freeze)
Reference V.:
Negative
Negative
8843
RISPERIDONE AND 9-HIDROXIRISPERIDONE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
Risperidone + 9-Hidroxirisperidone:
20.00 - 60.00 ug/L
Risperidone:
2.00 - 20.00 ug/L * 0.002436 = umol/L
10018
REARRANGEMENT IGH (14q32 REGION: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Sample:
5 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
01/03/2016
10149
RICKETTSIA CONORII DNA, CSF
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
1 mL Cerebrospinal liquid (-8 ºC - Freeze)
Reference V.:
Is not detected
10236
RECEPTOR NEURONAL NMDA ANTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
14/05/2013
10242
RYANODINE RECEPTOR ANTIBODIES, SERUM
Method:
Western-Blot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
10253
RICKETTSIA RICKETSII IgG ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/64 Titulo
Negative:
< 1/64 Titulo
10254
RICKETTSIA RICKETSII IgM ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/64 Titulo
Negative:
< 1/64 Titulo
10372
RECEPTOR NEURONAL NMDA ANTIBODIES, SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
14/05/2013
10398
Ri ANTIBODIES, CSF
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
09/07/2013
10740
RECEPTOR TSH GENE, BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10866
RETINOSIS PIGMENTARIA (57 GENES PANEL: NGS), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10870
RUBINSTEIN-TAYBI SYNDROME (CREBBP GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11027
REARRANGEMENT TEL/PDGFR-BETA t(5;12), BLOOD
Method:
RT-PCR Nested.
Mounting:
Delivery period:16
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
Reported for each case
Review:
11/07/2013
11042
REARRANGEMENT BCL6 GENE (3q27.3 REGION: FISH), BONE MARROW
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Sample:
3 mL Bone marrow RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
15/03/2014
11044
REORGANIZATION ALK GENE (REGION 2p23: FISH) , BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Sample:
5 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11152
REARRANGEMENT BCL2/IgH t(14;18)(q32;q21), BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:10
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11153
REARRANGEMENT BCL2/IgH t(14;18)(q32;q21), BIOPSY
Method:
Nested-PCR.
Mounting:
Delivery period:10
Sample:
Request form:
Clinical information required.
Reference V.:
Reported for each case
11154
REARRANGEMENT BCL1/IgH t(11;14) (q13;q32), BONE MARROW
Method:
Real Time PCR.
Mounting:
Delivery period:13
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11155
REARRANGEMENT BCL1/IgH t(11;14) (q13;q32), BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:13
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11182
REARRANGEMENT IGH (14q32 REGION: FISH), BONE MARROW
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Sample:
3 mL Bone marrow Sodium heparin RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
16/10/2014
11210
RETICULIN ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
11535
REARRANGEMENT MLL GENE (11q23.3 REGION: FISH), BONE MARROW
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Sample:
3 mL Bone marrow Sodium heparin RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
17/03/2014
11652
RNA POLIMERASA I ANTIBODIES, SERUM
11702
RECEPTOR NEURONAL AMPA ANTTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
11703
RECEPTOR NEURONAL AMPA ANTIBODIES, SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
14/05/2013
11811
RNA POLIMERASE III ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:35
Sample:
0.6 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 20 U/mL
Negative:
< 19 U/mL
11847
RECEPTOR PHOSPHOLIPASE A2 ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:13
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
Review:
08/04/2015
11921
RETIGABIN, SERUM
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:5
Sample:
Alt. 1 mL Plasma (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:

200 mg/day (after 1,5 - 2 h) 1.47 - 2.74 umol/L 1 = ug/L
14201
RESPIRATORY SYNCITIAL VIRUS ANTIBODIES IgG (EIA), SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:3
Sample:
300 uL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
14202
RESPIRATORY SYNCITIAL VIRUS ANTIBODIES IgM (EIA), SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:3
Sample:
300 uL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
14393
RECEPTOR NEURONAL GLICINE ANTIBODIES, SERUM
Method:
Immunocytochemistry
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14436
RENIN (ANGIOTENSIN), PLASMA. Supine Pos.
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
2.80 - 39.90 µUI/mL
Review:
17/12/2014
14437
RENIN (ANGIOTENSIN), PLASMA Upright. Pos.
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
4.40 - 46.10 µUI/mL
Review:
17/12/2014
14438
RENIN (ANGIOTENSIN) at -30 minuts, PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
Review:
17/12/2014
14439
RENIN (ANGIOTENSIN) at -15 minuts, PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
Review:
17/12/2014
14440
RENIN (ANGIOTENSIN), BASELINE
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

Standing position 4.40 - 46.10 µUI/mL
Supine position 2.80 - 39.90 µUI/mL
Review:
17/12/2014
14441
RENIN (ANGIOTENSIN) 120 m, PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
Review:
17/12/2014
14442
RENIN (ANGIOTENSIN) 240 m, PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
2 mL Plasma 4 h Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
Review:
17/12/2014
14640
RECEPTOR NEURONAL GLICINE ANTIBODIES, CSF
Method:
Immunocytochemistry
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14663
RETINOBLASTOMA (RB1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14676
RETT SYNDROME (MECP2 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14753
RETINOSCHISIS (RS1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14801
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 120 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 120m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Review:
03/07/2015
14835
RETINOSIS PIGMENTARIA (USH2A GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14917
REORGANIZATION ALK GENE (REGION 2p23: FISH), BIOPSY
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Request form:
Clinical information required.
Reference V.:
Reported for each case
15068
REORGANIZATION ROS1 GENE (6q22 REGION FISH), BIOPSY
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Reference V.:
Reported for each case
15079
RETT SYNDROME (MECP2 GENE: MLPA), CHORIONIC VILLI
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:30
Sample:
0.02 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15080
RETT SYNDROME (MECP2 GENE: SEQUENCING), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.02 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15107
RETT SYNDROME (MECP2 GENE: MLPA), AMNIOTIC FLUID
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15108
RETT SYNDROME (MECP2 GENE: SEQUENCING), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15306
RUBELLA VIRUS RNA, CSF
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
15396
RENIN ACTIVITY (ANGIOTENSIN), PLASMA after deambulation
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
15397
RENIN ACTIVITY (ANGIOTENSIN), PLASMA Postsaline
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
Not available
15553
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 60 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 60m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

15576
RHD GENOTYPE, BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:18
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15637
RENIN ACTIVITY (ANGIOTENSIN), PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

Standing position 0.60 - 4.18 ng/mL/h
Supine position 0.32 - 1.84 ng/mL/h
15638
RENIN ACTIVITY (ANGIOTENSIN), PLASMA Basal
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Baseline plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

Standing position 0.60 - 4.18 ng/mL/h
Supine position 0.32 - 1.84 ng/mL/h
15639
RENIN ACTIVITY (ANGIOTENSIN), PLASMA Standing position
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Standing position plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
0.60 - 4.18 ng/mL/h
15640
RENIN ACTIVITY (ANGIOTENSIN), PLASMA Supine position
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Supine position plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
0.32 - 1.84 ng/mL/h
15670
Ro52 (SS-A) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15673
Ro60 (SS-A) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15674
RNPa (NUCLEAR RIBONUCLEOPROTEIN) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15675
RNP68 (NUCLEAR RIBONUCLEOPROTEIN) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15697
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 180 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 180m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

15729
RUFINAMIDE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
5.00 - 30.00 mg/L * 4.198 = µmol/l
15916
RENIN ACTIVITY (ANGIOTENSIN), PLASMA 300 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
600 uL Plasma 300 min. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

16001
ROTAVIRUS ANTIBODIES IgG, SERUM
Method:
Complement fixation.
Mounting:
Delivery period:23
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 1.00 Indice
Negative:
< 1.00 Indice
16002
ROTAVIRUS ANTIBODIES IgM, SERUM
Method:
Complement fixation.
Mounting:
Delivery period:23
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 1.00 Indice
Negative:
< 1.00 Indice